NJ A1526Failedas of 2026-01-13
Establishes Psilocybin Behavioral Health Access and Therapy Pilot Program; appropriates $6 million.
Plain-English summary
What happened: This New Jersey bill would establish a Psilocybin Behavioral Health Access and Therapy Pilot Program with $6 million in appropriations and has been introduced and referred to the Assembly Health Committee.
Why it matters: A state-sanctioned psilocybin pilot program would create a new regulated therapeutic market with potential licensing and operational frameworks relevant to behavioral health service providers.
Affects: patients
LATEST ACTION: Introduced, Referred to Assembly Health Committee
READ THE FULL BILL TEXT →Follow New Jersey cannabis bills for free. One plain-English email a week with every bill that moved, including this one.
Get the free digestMore New Jersey cannabis bills
S4635Aligns State restrictions on sale of hemp products and intoxicating hemp beverages with federal law.Passed ChamberA5649Prohibits law enforcement officers, first responders, CDL drivers, or persons who operate heavy equipment from engaging in recreational use of cannabis items.IntroducedA5683Allows Cannabis Regulatory Commission to award competitive grants from Social Equity Excise Fee proceeds.IntroducedA5604Aligns State restrictions on sale of hemp products and intoxicating hemp beverages with federal law.IntroducedS4726Allows Cannabis Regulatory Commission to award competitive grants from Social Equity Excise Fee proceeds.IntroducedS4685Prohibits law enforcement officers, first responders, CDL drivers, or persons who operate heavy equipment from engaging in recreational use of cannabis items.IntroducedA5476Requires training for employees in certain settings to recognize and respond to indications of intoxication in children from consumption of cannabis item.IntroducedA5463Requires cannabis retailer to display notice of risks of high potency cannabis.Introduced
ALL NEW JERSEYCANNABIS LAWS & BILLS →Legislative data via LegiScan, licensed under CC BY 4.0. Summaries and categorization by CannaSignal. Regulatory information, not legal advice.